Header Logo

Connection

OLIVE ECKSTEIN to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications OLIVE ECKSTEIN has written about Antibodies, Neutralizing.
OLIVE ECKSTEIN
Connection Strength
0.043
Antibodies, Neutralizing
  1. Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis Rheumatol. 2025 Feb; 77(2):226-238.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.